Trial Profile
Analgesic Effect Of Topical Nepafenac 0.1% On Pain Related To Intravitreal Injections: A Randomized Crossover Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 May 2017
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary) ; Nepafenac (Primary)
- Indications Ocular pain
- Focus Therapeutic Use
- 04 May 2017 Status changed from active, no longer recruiting to completed.
- 24 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.
- 24 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.